For research use only. Not for therapeutic Use.
JBJ-03-142-02(Cat No.:I029749)is a small molecule compound that has been researched for its potential in treating various diseases, particularly those with underlying inflammatory or autoimmune components. It functions as an inhibitor targeting specific molecular pathways involved in immune cell activation and inflammation. Studies have shown that JBJ-03-142-02 may help modulate immune responses and reduce the progression of inflammatory disorders. Although primarily investigated in preclinical models, the compound shows promise for its therapeutic applications in conditions such as rheumatoid arthritis and other immune-related diseases.
Catalog Number | I029749 |
CAS Number | 2068806-31-3 |
Synonyms | JBJ-03-142-02 |
Molecular Formula | C25H22FN7O3 |
Purity | 98% |
Solubility | Soluble in DMSO |
Appearance | Solid powder |
Storage | Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years). |
IUPAC Name | (4-fluorophenyl)methyl N-[2-[(1-methylpyrazol-4-yl)amino]pyrimidin-4-yl]-N-[3-(prop-2-enoylamino)phenyl]carbamate |
InChI | InChI=1S/C25H22FN7O3/c1-3-23(34)29-19-5-4-6-21(13-19)33(25(35)36-16-17-7-9-18(26)10-8-17)22-11-12-27-24(31-22)30-20-14-28-32(2)15-20/h3-15H,1,16H2,2H3,(H,29,34)(H,27,30,31) |
InChIKey | IFRXGTCPIGRGHP-UHFFFAOYSA-N |
SMILES | CN1C=C(C=N1)NC2=NC=CC(=N2)N(C3=CC=CC(=C3)NC(=O)C=C)C(=O)OCC4=CC=C(C=C4)F |